交通・アクセス
Notice with respect to a license agreement with uniQure and the development of gene therapy encoding a new enzyme, “modified NAGA”, for Fabry disease

Tokyo Metropolitan Institute of Medical Science was established in April 2011 by the merger of three Tokyo metropolitan government-operated institutes, namely, Tokyo Metropolitan Institute for Neuroscience, Tokyo Institute of Psychiatry, and the Tokyo Metropolitan Institute of Medical Science. The ultimate goal of the institute is to improve the health and welfare of the citizens of the Tokyo city as well as those of our country through original discovery on the pathology and molecular basis of diseases and through development of novel strategies for prediction, prevention, diagnosis and therapy of various diseases including mental disorders.

TOPICS

27 November 2018
Notice with respect to a license agreement with uniQure and the development of gene therapy encoding a new enzyme, “modified NAGA”, for Fabry disease

TOPICS

EVENT

18th TMIMS International Symposium ”Structured nucleic acids: its recognition mechanisms, biology and diseases ” 

PAMPHLET

TMIMS 2017
Download PDF(P1-p76/12.1MB)
ページの先頭へ